Inconsistent advice

Label warnings on the possible cardiovascular risk of ADHD medications are inconsistent and ambiguous, say experts  Product labelling warning of the cardiovascular risks of ADHD medication is inconsistent, say researchers who compared labelling across four countries, including Australia. Studying medication labelling, both for consumers and healthcare professionals, for five ADHD medications in Australia, Canada, the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pharmacies 'sitting ducks' for robberies
Next Research Roundup